EcoDrugPlus

Estrogen Related Receptor Gamma

Ensembl ID : ENSECRG00000013623
Gene Symbol: ESRRG
3 Cross references
206 Possible Orthologues:

Exportin 1

Ensembl ID : ENSECRG00000019440
Gene Symbol: XPO1
2 Cross references
296 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSECRG00000001906
Gene Symbol: FDPS
3 Cross references
269 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSECRG00000004603
Gene Symbol: FDFT1
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSECRG00000004225
Gene Symbol: FGF2
3 Cross references
122 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-Like

Ensembl ID : ENSECRG00000000297
Gene Symbol: LOC114650026
3 Cross references
293 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSECRG00000016325
Gene Symbol: FGFR2
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSECRG00000018877
Gene Symbol: FGFR3
3 Cross references
197 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSECRG00000007743
Gene Symbol: FLT3
3 Cross references
134 Possible Orthologues:

Fms Related Tyrosine Kinase 1

Ensembl ID : ENSECRG00000007592
Gene Symbol: FLT1
3 Cross references
199 Possible Orthologues:

Folate Hydrolase 1b

Ensembl ID : ENSECRG00000003672
Gene Symbol: FOLH1B
3 Cross references
340 Possible Orthologues:

Folate Receptor Alpha-Like

Ensembl ID : ENSECRG00000004902
Gene Symbol: LOC114649967
3 Cross references
436 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).